Physiologic Expression of Sf3b1(K700E) Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation

Obeng, Esther A., Chappell, Ryan J., Seiler, Michael, Chen, Michelle C., Campagna, Dean R., Schmidt, Paul J., Schneider, Rebekka K., Lord, Allegra M. +12 more·2016·Cancer Cell

DOI 10.1016/j.ccell.2016.08.006

Cited by (380)

Items 201–300 of 380

Genome-wide screening identifies cell-cycle control as a synthetic lethal pathway with SRSF2P95H mutation
Jane Jialu Xu, Alistair Morgan Chalk, Iva Nikolić, Kaylene J. Simpson, Monique F. M. A. Smeets, Carl R. Walkley · 2021 · Blood Advances
ATP5A1 Participates in Transcriptional and Posttranscriptional Regulation of Cancer-Associated Genes by Modulating Their Expression and Alternative Splicing Profiles in HeLa Cells
Yisa Song, BA, Fei Wang, Yaxun Wei, Dong Chen, BA Gang Deng · 2021 · Technology in Cancer Research & Treatment
Splicing Modulation Results in Aberrant Isoforms and Protein Products of p53 Pathway Genes and the Sensitization of B Cells to Non-Genotoxic MDM2 Inhibition
Erhan Aptullahoğlu, Carmela Ciardullo, Jonathan Peter Wallis, Helen J. Marr, Scott R Marshall, Nick P. Bown, Elaine Willmore, John Lunec · 2023 · International Journal of Molecular Sciences
New Insight Into the Biology, Risk Stratification, and Targeted Treatment of Myelodysplastic Syndromes
Mintallah Haider, Eric J. Duncavage, Khalid F. Afaneh, Rafael L. Bejar, Alan F. List · 2017 · American Society of Clinical Oncology Educational Book
Chromatin-Spliceosome Mutations in Acute Myeloid Leukemia
Yotaro Ochi, Seishi Ogawa · 2021 · Cancers
Recurrent Spliceosome Mutations in Cancer: Mechanisms and Consequences of Aberrant Splice Site Selection
Carlos A. Niño, Rossella Scotto di Perrotolo, Simona Polo · 2022 · Cancers
Cancer-Related Mutations Alter RNA-Driven Functional Cross-Talk Underlying Premature-Messenger RNA Recognition by Splicing Factor SF3b
Angelo Spinello, Pavel Janoš, Riccardo Rozza, Alessandra Magistrato · 2023 · The Journal of Physical Chemistry Letters
Mutant SF3B1 promotes malignancy in PDAC
Patrik Simmler, Eleonora I. Ioannidi, Tamara Mengis, Kim Fabiano Marquart, Simran Asawa, Kjong-Van Lehmann, André Kahles, Tinu M. Thomas, Cornelia Schwerdel, Nicola Aceto et al. · 2023 · eLife
Genetic and environmental risks for clonal hematopoiesis and cancer
Stephanie Franco, Lucy A. Godley · 2024 · The Journal of Experimental Medicine
Modeling human RNA spliceosome mutations in the mouse: not all mice were created equal
Jane Jialu Xu, Monique F. M. A. Smeets, Shuh Ying Tan, Meaghan Wall, Louise E. Purton, Carl R. Walkley · 2018 · Experimental Hematology
Inflammasome Activation in Myeloid Malignancies—Friend or Foe?
Nicola Daniele Andina, Nicolas Bonadies, Ramanjaneyulu Allam · 2022 · Frontiers in Cell and Developmental Biology
Genetic basis of myelodysplastic syndromes
Seishi Ogawa · 2020 · Proceedings of the Japan Academy Series B
Erythroid Differentiation Enhances RNA Mis-Splicing in SF3B1 -Mutant Myelodysplastic Syndromes with Ring Sideroblasts
Pedro Luís Moura, Teresa Mortera Blanco, Isabel Juliana Hofman, Gabriele Todisco, Warren W. Kretzschmar, Ann-Charlotte Björklund, Maria Creignou, Michael Hagemann-Jensen, Christoph Ziegenhain, David Cabrerizo Granados et al. · 2023 · Cancer Research
Cancer-associated mutations in SF3B1 disrupt the interaction between SF3B1 and DDX42
Bo Zhao, Zhuang Li, Rui Qian, Gang Liu, Mingyue Fan, Zehua Liang, Xin Hu, Youzhong Wan · 2022 · The Journal of Biochemistry
SF3B1 mutations in primary and secondary myelofibrosis: Clinical, molecular and prognostic correlates
Giuseppe Gaetano Loscocco, Paola Guglielmelli, Francesco Mannelli, Barbara Mora, Carmela Mannarelli, Giada Rotunno, Fabiana Pancani, Chiara Maccari, Niccolò Bartalucci, Simone Romagnoli et al. · 2022 · American Journal of Hematology
Identifying a possible new target for diagnosis and treatment of postmenopausal osteoporosis through bioinformatics and clinical sample analysis
Ting Liu, Jiajun Huang, Dongni Xu, Yuxi Li · 2021 · Annals of Translational Medicine
Targeting Cancer Gene Dependencies with Anthrax-Mediated Delivery of Peptide Nucleic Acids
Zeyu Mike Lu, Brenton R. Paolella, Nicholas L. Truex, Alexander R. Loftis, Xiaoli Liao, Amy E. Rabideau, Meredith S. Brown, John P. Busanovich, Rameen Beroukhim, Bradley L. Pentelute · 2020 · ACS Chemical Biology
Titration of SF3B1 Activity Reveals Distinct Effects on the Transcriptome and Cell Physiology
Karen S. Kim Guisbert, Isiah Mossiah, Eric Guisbert · 2020 · International Journal of Molecular Sciences
How Driver Oncogenes Shape and Are Shaped by Alternative Splicing Mechanisms in Tumors
Weronika Wojtyś, Magdalena Oroń · 2023 · Cancers
Small molecule inhibition of RNA binding proteins in haematologic cancer
Amit Kumar Jaiswal, Michelle L. Thaxton, Georgia Scherer, Jacob P. Sorrentino, Neil K. Garg, Dinesh S. Rao · 2024 · RNA Biology
SF3B1 mutation predicts unfavorable treatment-free survival in Chinese chronic lymphocytic leukemia patients
Yi Miao, Yixin Zou, Danling Gu, Hongcheng Zhu, Huayuan Zhu, Li Wang, Jin‐Hua Liang, Yi Xia, Jia‐Zhu Wu, Chunlin Shao et al. · 2019 · Annals of Translational Medicine
Comparison and Implications of Mutational Profiles of Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: A Meta-Analysis
Ziqi Wan, Bing Han · 2020 · Frontiers in Oncology
RNA Regulators in Leukemia and Lymphoma
Camila Prieto, Michael G. Kharas · 2019 · Cold Spring Harbor Perspectives in Medicine
Targeting low-risk myelodysplastic syndrome with novel therapeutic strategies
Gaurang Trivedi, Daichi Inoue, Lingbo Zhang · 2021 · Trends in Molecular Medicine
Post-transcriptional regulation of erythropoiesis
Yanan Li, Haihang Zhang, Bin Hu, Pan Wang, Wei Wang, Jing Liu · 2023 · Blood Science
Mouse Models of Erythropoiesis and Associated Diseases
Matthew P. Parker, Kenneth R. Peterson · 2017 · Methods in molecular biology
Decoding Spliceosome Dynamics through Computation and Experiment
Pavlína Pokorná, Jana Aupič, Sebastian M. Fica, Alessandra Magistrato · 2025 · Chemical Reviews
Clinical and Mechanistic Implications of R-Loops in Human Leukemias
Seo Yun Lee, Kyle M. Miller, Jae‐Jin Kim · 2023 · International Journal of Molecular Sciences
SF3B1 Mutations Are Associated with Resistance to Non-Genotoxic MDM2 Inhibition in Chronic Lymphocytic Leukemia
Erhan Aptullahoğlu, Jonathan Peter Wallis, Helen J. Marr, Scott R Marshall, Nick P. Bown, Elaine Willmore, John Lunec · 2023 · International Journal of Molecular Sciences
The evolution of preclinical models for myelodysplastic neoplasms
Alain Antoine Mina, Steven Zivko Pavletic, Peter D. Aplan · 2024 · Leukemia
Precision Medicine Approaches in Acute Myeloid Leukemia with Adverse Genetics
Nicole Santoro, P. Salutari, M. Di Ianni, Andrea Marra · 2024 · International Journal of Molecular Sciences
Altered RNA export by SF3B1 mutants confers sensitivity to nuclear export inhibition
Sana Chaudhry, Felipe Beckedorff, Shaista Shabbir Jasdanwala, Tulasigeri M. Totiger, Maurizio Affer, Abimbola Eunice Lawal, Skye Montoya, Francesco Tamiro, Olivia Tonini, Alexandra Chirino et al. · 2024 · Leukemia
Cancer-associated SF3B1-K700E mutation controls immune responses by regulating T reg function via aberrant Anapc13 splicing
Yun Shi, Wencan Zhang, Qiong Jia, Xiancai Zhong, Prajish Sundaram Iyer, Hongmin Wu, Yate‐Ching Yuan, Yuqi Zhao, Lianjun Zhang, Lili Wang et al. · 2024 · Science Advances
Therapeutic targeting of RNA splicing in myelodysplasia
Young Joon Kim, Omar Ibrahim Abdel-Wahab · 2017 · Seminars in Hematology
Stem Cells in the Myelodysplastic Syndromes
Di Zhan, Christopher Y. Park · 2021 · Frontiers in Aging
RNA Splicing as a Therapeutic Target in Cancer
Alexander M. Lewis, Kenyon Weis, Omar Ibrahim Abdel-Wahab · 2025 · The Annual Review of Pharmacology and Toxicology
Distinct characteristics of VEXAS-causative UBA1 M41 and recurrent functional non-M41 mutations
Maki Sakuma, Amy K. Wang, Samuel J. Magaziner, Sachiko P. Keane, Manja Meggendorfer, Wolfgang Kern, Claudia Haferlach, Torsten Haferlach, David B. Beck, Wencke Walter · 2025 · Leukemia
Therapeutic approaches targeting splicing factor mutations in myelodysplastic syndromes and acute myeloid leukemia
John Figg, Juan Martin Barajas, Esther A. Obeng · 2021 · Current Opinion in Hematology
RNA splicing as a therapeutic target in myelodysplastic syndromes
Chun-Chih Tseng, Esther A. Obeng · 2024 · Seminars in Hematology
Perturbation of mRNA splicing in liver cancer: insights, opportunities and challenges
Qi Jia, Xiaoxiao Sun, Haoyu Li, Jianglong Guo, Kongyan Niu, Kui Ming Chan, René Bernards, Wenxin Qin, Haojie Jin · 2024 · Gut
Spliceosomal factor mutations and mis-splicing in MDS
Courtney E. Hershberger, Noah J. Daniels, Richard A. Padgett · 2020 · Best Practice & Research Clinical Haematology
Concurrent Zrsr2 mutation and Tet2 loss promote myelodysplastic neoplasm in mice
Cristian García-Ruiz, Cristina Martínez-Valiente, Lourdes Cordón, Alessandro Liquori, Raúl Fernández‐González, Eva Pericuesta, Juan Sandoval, José Cervera, Alfonso Gutiérrez‐Adán, Alejandra Sanjuán-Pla · 2022 · Leukemia
Hematopoietic Stem Cell: Regulation and Nutritional Intervention
Siyuan Sun, Yingxue Han, Yumei Lei, Yifei Yu, Yanbin Dong, Juan Chen · 2023 · Nutrients
Murine models of erythroid 5ALA synthesis disorders and their conditional synthetic lethal dependency on pyridoxine
Sarah Ducamp, Anoop K. Sendamarai, Dean R. Campagna, Desmond Wai Loon Chin, Yuko Fujiwara, Paul Joseph Schmidt, Mark D. Fleming · 2024 · Blood
JAK2 exon 12 mutation in myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis: Not an exclusive mutation to polycythaemia vera
Tadaaki Inano, Marito Araki, Soji Morishita, Misa Imai, Hajime Yasuda, Hideaki Nitta, Masafumi Ito, Yoko Edahiro, Tomonori Ochiai, Kyohei Misawa et al. · 2019 · British Journal of Haematology
Clonal haematopoiesis of emerging significance
Danielle E. Hammond, Sanam Loghavi · 2021 · Pathology
Clonal hematopoiesis and myeloid malignancies: clonal dynamics and clinical implications
Chiara Elena, Anna Gallì, Elisa B. Bono, Gabriele Todisco, Luca Malcovati · 2021 · Current Opinion in Hematology
The spliceosome factor sart3 regulates hematopoietic stem/progenitor cell development in zebrafish through the p53 pathway
Yan Zhao, Mei Wu, Jing Li, Ping Meng, Jiakui Chen, Zhibin Huang, Jin Xu, Zilong Wen, Wenqing Zhang, Yiyue Zhang · 2021 · Cell Death and Disease
In Silico Analysis of a Highly Mutated Gene in Cancer Provides Insight into Abnormal mRNA Splicing: Splicing Factor 3B Subunit 1K700E Mutant
Asmaa Samy, Barış Ethem Süzek, Mehmet Kemal Özdemir, Özge Şensoy · 2020 · Biomolecules
The role of SF3B1 and NOTCH1 in the pathogenesis of leukemia
Shiva Abolhasani, Seyyed Sina Hejazian, Vahid Karpisheh, Atefeh Khodakarami, Hamed Mohammadi, Jamshid Gholizadeh Navashenaq, Mohammad Hojjat‐Farsangi, Farhad Jadidi‐Niaragh · 2022 · IUBMB Life
Hyperactivation of NF-κB signaling in splicing factor mutant myelodysplastic syndromes and therapeutic approaches
Andrea Pellagatti, Jacqueline Boultwood · 2024 · Advances in Biological Regulation
U2AF1 mutation connects DNA damage to the alternative splicing of RAD51 in lung adenocarcinomas
Chuanhui Chen, Pinglang Zhou, Zhizhe Zhang, Yu Liu · 2022 · Clinical and Experimental Pharmacology and Physiology
Noncoding rules of survival: epigenetic regulation of normal and malignant hematopoiesis
LaShanale M. Wallace, Esther A. Obeng · 2023 · Frontiers in Molecular Biosciences
Blood Relatives: Splicing Mechanisms underlying Erythropoiesis in Health and Disease
Kirsten A. Reimer, Karla M. Neugebauer · 2018 · F1000Research
Emerging single-cell tools are primed to reveal functional and molecular heterogeneity in malignant hematopoietic stem cells
Mairi S. Shepherd, David G. Kent · 2019 · Current Opinion in Hematology
Induced pluripotent stem cell models of myeloid malignancies and clonal evolution
Andreea Reilly, Sergei R. Doulatov · 2021 · Stem Cell Research
SplicingFactory—splicing diversity analysis for transcriptome data
Benedek Dankó, Péter Szikora, Tamás Pór, Alexa Szeifert, Endre Sebestyén · 2021 · Bioinformatics
DHX9-mediated pathway contributes to the malignant phenotype of myelodysplastic syndromes
Nanfang Huang, Song Yang, Wenhui Shi, Juan Guo, Zheng Zhang, Qi He, Lingyun Wu, Xiao Li, Feng Xu · 2023 · iScience
Refractory macrocytic anemias in patients with clonal hematopoietic disorders and isolated mutations of the spliceosome gene ZRSR2
Roger A. Fleischman, Shannon Somer Stockton, Christopher Ramin Cogle · 2017 · Leukemia Research
Degenerate minigene library analysis enables identification of altered branch point utilization by mutant splicing factor 3B1 (SF3B1)
Abhishek Kumar Gupta, Tushar Murthy, Kiran Vinod-Paul, Oscar Ramirez, Joseph B. Fisher, Sridhar Rao, Alexander B Rosenberg, Georg Seelig, Alex C. Minella, Manoj M. Pillai · 2018 · Nucleic Acids Research
Does SF3B1/TET2 Double Mutation Portend Better or Worse Prognosis Than Isolated SF3B1 or TET2 Mutation?
Jinming Song, Lynn C. Moscinski, HAILING ZHANG, XIAOHUI ZHANG, Mohammad Hussaini · 2018 · Cancer Genomics & Proteomics
Single-cell multi-omics defines the cell-type specific impact of splicing aberrations in human hematopoietic clonal outgrowths
Federico Gaiti, Paulina Chamely, Allegra G. Hawkins, Mariela Cortés-López, Ariel D. Swett, Saravanan Ganesan, Tarek H. Mouhieddine, Xiaoguang Dai, Lloyd Kluegel, Celine Y. Chen et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
SUGP1 loss drives SF3B1 hotspot mutant missplicing in cancer
Peiqi Xing, Pedro Bak‐Gordon, Jindou Xie, Jian Zhang, Zhaoqi Liu, James L. Manley · 2025 · Cell Reports
An inflammatory T-cell-stromal axis contributes to hematopoietic stem/progenitor cell failure and clonal evolution in human myelodysplastic syndrome
Lanpeng Chen, Yujie Bian, Eline Pronk, Claire van Dijk, Tim V. D. van Tienhoven, Remco Michiel Hoogenboezem, Eric M. Bindels, Dennis A. Bosch, Sadaf Fazeli, Aniek O. de Graaf et al. · 2025 · Nature Communications
Studying the connection between SF3B1 and four types of cancer by analyzing networks constructed based on published research
Asmaa Samy, Mehmet Kemal Özdemir, Reda Alhajj · 2023 · Scientific Reports
Analysis of distinct SF3B1 hotspot mutations in relation to clinical phenotypes and response to therapy in myeloid neoplasia
Vera Ademà, Jack Khouri, Ying Ni, Heesun Joyce Rogers, Cassandra M Kerr, Hassan K. Awada, Yasunobu Nagata, Teodora Kuzmanovic, Anjali S. Advani, Aaron Thomas Gerds et al. · 2020 · Leukemia & lymphoma/Leukemia and lymphoma
RNA-binding proteins as drivers of AML and novel therapeutic targets
Tingyu Qin, Ying Cheng, Xiaozhong Wang · 2022 · Leukemia & lymphoma/Leukemia and lymphoma
Splicing factor deficits render hematopoietic stem and progenitor cells sensitive to STAT3 inhibition
Kathryn S. Potts, Rosannah C. Cameron, Amina Metidji, Noura Ghazale, LaShanale M. Wallace, Ana I. Leal-Cervantes, Reid Palumbo, Juan Martin Barajas, Varun Gupta, Srinivas Aluri et al. · 2022 · Cell Reports
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing
Heather L. Drexler, Karine Choquet, L. Stirling Churchman · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
RNA binding protein‐directed control of leukemic stem cell evolution and function
Pratik Joshi, Ava Keyvani Chahi, Lina Liu, Steven Moreira, Ana Vujovic, Kristin J. Hope · 2024 · HemaSphere
The Impact of Spliceosome Inhibition in SF3B1 -Mutated Uveal Melanoma
Josephine Q.N. Nguyen, Wojtek Drabarek, Aïsha M. C. H. J. Leeflang, Tom Brands, Thierry P. P. van den Bosch, Robert M. Verdijk, Harmen J.G. van de Werken, Job van Riet, Dion A. Paridaens, Annelies de Klein et al. · 2024 · Investigative Ophthalmology & Visual Science
Mechanistic Insights of Aberrant Splicing with Splicing Factor Mutations Found in Myelodysplastic Syndromes
Naoyuki Kataoka, Eri Matsumoto, So Masaki · 2021 · International Journal of Molecular Sciences
Two oppositely-charged sf3b1 mutations cause defective development, impaired immune response, and aberrant selection of intronic branch sites in Drosophila
Bei Zhang, Zhan Ding, Liang Li, Ling-Kun Xie, Yujie Fan, Yong‐Zhen Xu · 2021 · PLoS Genetics
Pathogenic Roles of RNA-Binding Proteins in Sarcomas
Yu Hai, Asuka Kawachi, Xiaodong He, Akihide Yoshimi · 2022 · Cancers
Targeting splicing for hematological malignancies therapy
Monika Szelest, Krzysztof Giannopoulos · 2024 · BMC Genomics
SF3B1 thermostability as an assay for splicing inhibitor interactions
Angela N. Amorello, Guddeti Chandrashekar Reddy, Bruno N. Melillo, Benjamin F. Cravatt, Arun Kumar Ghosh, Melissa S. Jurica · 2024 · Journal of Biological Chemistry
Alternative splicing of modulatory immune receptors in T lymphocytes: a newly identified and targetable mechanism for anticancer immunotherapy
Shay Tzaban, Ori Stern, Elad Zisman, Galit Eisenberg, Shiri Klein, Shoshana Frankenburg, Michal Lotem · 2025 · Frontiers in Immunology
Establishment of a High‐risk MDS/AML Cell Line YCU‐AML1 and its Xenograft Model Harboring t(3;3) and Monosomy 7
Hiroyoshi Kunimoto, Yumi Fukuchi, Koichi Murakami, Junji Ikeda, Hiroshi Teranaka, Ikuma Kato, Takuya Miyazaki, Makiko Enaka, Takayuki Mitsuhashi, Etsuko Yamazaki et al. · 2020 · HemaSphere
Mouse Models of Frequently Mutated Genes in Acute Myeloid Leukemia
Sagarajit Mohanty, Michael Heuser · 2021 · Cancers
Mouse Models of Myeloid Malignancies
Faisal Basheer, George S. Vassiliou · 2020 · Cold Spring Harbor Perspectives in Medicine
Clonal haematopoiesis associates with distinct cytometric changes of red blood cells and platelets
Jonas B. Salzbrunn, Isabelle A. van Zeventer, Aniek O. de Graaf, Stefanie Klatte, L. Joost van Pelt, Priscilla Kamphuis, Maaike G.J.M. van Bergen, Avinash G. Dinmohamed, Bert A. van der Reijden, Joachim Linssen et al. · 2025 · British Journal of Haematology
PARP inhibition leads to synthetic lethality with key splicing-factor mutations in myelodysplastic syndromes
Fangliang Zhang, Jianai Sun, Lei Zhang, Ruiqi Li, Yanzhen Wang, Huichao Geng, Chao Shen, Ling Li, Liang Chen · 2024 · British Journal of Cancer
Engineering Oncogenic Hotspot Mutations on SF3B1 via CRISPR-Directed PRECIS Mutagenesis
Mike Minh Fernandez, Qiong Jia, Lei Yu, Xuesong Wang, Kevyn L. Hart, Zhenyu Jia, Ren-Jang Lin, Lili Wang · 2024 · Cancer Research Communications
Splicing together the origins of MDS-RS
Sara E. Meyer · 2017 · Blood
Splicing dysfunction and disease: The case of granulopoiesis
Maria-Cristina Keightley, Graham John Lieschke · 2017 · Seminars in Cell and Developmental Biology
Epigenetic vulnerabilities of leukemia harboring inactivating EZH2 mutations
Mona Alqazzaz, Genna M. Luciani, Victoria Vu, Raquel A. C. Machado, Magdalena M. Szewczyk, Ella C. Adamson, Sehyun Cheon, Fengling Li, C.H. Arrowsmith, Mark David Minden et al. · 2023 · Experimental Hematology
Targeting the transcription cycle and RNA processing in cancer treatment
Lin Zhang, Youyou Zhang, Xiaowen Hu · 2021 · Current Opinion in Pharmacology
Minor introns impact on hematopoietic malignancies
Koutarou Nishimura, Wataru Saika, Daichi Inoue · 2024 · Experimental Hematology
Clonal hematopoiesis of indeterminate potential (CHIP): A potential contributor to lymphoma
QingQing Luo, Lili Zhou, DaYa Luo, Li Yu · 2024 · Critical Reviews in Oncology/Hematology
SF3B1-mutant models of RNA mis-splicing uncover UBA1 as a therapeutic target in myelodysplastic neoplasms
Jonas Thier, Sophia Hofmann, Katharina Miria Kirchhof, Gabriele Todisco, Teresa Mortera Blanco, Ingrid Lilienthal, Dimitris C. Kanellis, Indira Barbosa, Ann-Charlotte Björklund, André G. Deslauriers et al. · 2025 · Leukemia
New drug discovery approaches targeting recurrent mutations in chronic lymphocytic leukemia
Rupal Tripathi, Eriong Lee‐Vergés, Morihiro Higashi, Neus Giménez, Laia Rosich, Mònica López‐Guerra, Dolors Colomer · 2017 · Expert Opinion on Drug Discovery
Transcription Factors, R-Loops and Deubiquitinating Enzymes: Emerging Targets in Myelodysplastic Syndromes and Acute Myeloid Leukemia
Silvia M.L. Barabino, Elisabetta Citterio, Antonella Ellena Ronchi · 2021 · Cancers
Therapeutic approaches for the management of higher risk myelodysplastic syndromes
Chen Wang, David Andrew Sallman · 2022 · Leukemia & lymphoma/Leukemia and lymphoma
Therapeutic strategies for aberrant splicing in cancer and genetic disorders
Wenhua Shi, Jingqun Tang, Juanjuan Xiang · 2024 · Clinical Genetics
Clonal trajectories and cellular dynamics of myeloid neoplasms with SF3B1 mutations
Hassan K. Awada, Cassandra M Kerr, Arda Durmaz, Vera Ademà, Carmelo Gurnari, Simona Pagliuca, Misam Zawit, Sunisa Kongkiatkamon, Heesun Joyce Rogers, Yogen Saunthararajah et al. · 2021 · Leukemia
The Etiology of Acute Leukemia
Jessica N. Nichol, Mena Kinal, Wilson H. Miller · 2017 · Springer eBooks
Clonal Hematopoiesis in Nonmalignant Disease: Functional Consequences of Mutated Immune Cells by Clonal Hematopoiesis in the Diseased Tissue
Youngil Koh, Isak W. Tengesdal, Siddhartha Jaiswal · 2025 · Annual Review of Pathology Mechanisms of Disease
What are the most promising new agents in myelodysplastic syndromes?
Namrata S. Chandhok, Prajwal Chaitanya Boddu, Steven D. Gore, Thomas Prébet · 2019 · Current Opinion in Hematology
Identification of UBA7 expression downregulation in myelodysplastic neoplasm with SF3B1 mutations
Sael M. Alatawi, Othman Rashed Alzahrani, Fuad Abdullah Alatawi, Ibrahim Abdullah Almazni, Alhomidi Almotiri, Fahad M. Almsned · 2025 · Scientific Reports
Inhibition of the minor spliceosome restricts the growth of a broad spectrum of cancers
Karen Doggett, Kimberly J Morgan, Stephen Mieruszynski, Benjamin B. Williams, Anouk M. Olthof, Alexandra L. Garnham, Michael J. G. Milevskiy, Lachlan W. Whitehead, Janine L. Coates, Michael Büchert et al. · 2025 · EMBO Reports